Stage IB Breast Cancer Terminated Phase 1 Trials for Pazopanib (DB06589)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029218 (Stage IB Breast Cancer) | Terminated | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00450879 | Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery | Treatment |